Pfizer (NYSE:PFE) Chairman and Chief Executive Officer Albert Bourla said the drugmaker has addressed several major headwinds that weighed on investor attention, including policy uncertainty, declining COVID-19-related demand and upcoming losses of exclusivity for certain products. Speaking at a Morgan Stanley conference, Bourla said Pfizer had reached agreements related to tariffs and most-favored-nation pricing policies, […]